Spire Wealth Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,700
Closed -$91.7K 2376
2023
Q3
$91.7K Hold
3,700
﹤0.01% 980
2023
Q2
$104K Hold
3,700
﹤0.01% 958
2023
Q1
$82.6K Hold
3,700
﹤0.01% 1024
2022
Q4
$98K Hold
3,700
0.01% 746
2022
Q3
$105K Hold
3,700
0.01% 697
2022
Q2
$77K Sell
3,700
-400
-10% -$7.5K ﹤0.01% 1126
2022
Q1
$89K Buy
4,100
+300
+8% +$6.51K ﹤0.01% 1203
2021
Q4
$105K Sell
3,800
-2,100
-36% -$50.9K ﹤0.01% 1381
2021
Q3
$125K Buy
5,900
+4,900
+490% +$91.9K ﹤0.01% 1113
2021
Q2
$17K Buy
+1,000
New +$15.3K ﹤0.01% 1933

Other funds holding CCRN

Spire Wealth Management's CCRN Position: Q4 2023 in Review

Spire Wealth Management sold out of Cross Country Healthcare (CCRN) in Q4 2023, closing a stake of 3,700 shares — an estimated $91.7K sold.

Spire Wealth Management first reported a position in CCRN in Q2 2021 and held it in 10 quarters. The position peaked at $125K in Q3 2021. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2023.

  • Spire Wealth Management reported no remaining Cross Country Healthcare position as of Q4 2023 after selling out during the quarter.
  • Spire Wealth Management sold 3,700 Cross Country Healthcare shares in Q4 2023, an estimated $91.7K.
  • Spire Wealth Management first reported a position in Cross Country Healthcare in Q2 2021 and held it in 10 quarters.
  • Spire Wealth Management's Cross Country Healthcare position peaked at $125K in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2023.

Based on Spire Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.